NZ195933A - Sustained-release pharmaceutical compositions in tablet form - Google Patents
Sustained-release pharmaceutical compositions in tablet formInfo
- Publication number
- NZ195933A NZ195933A NZ195933A NZ19593380A NZ195933A NZ 195933 A NZ195933 A NZ 195933A NZ 195933 A NZ195933 A NZ 195933A NZ 19593380 A NZ19593380 A NZ 19593380A NZ 195933 A NZ195933 A NZ 195933A
- Authority
- NZ
- New Zealand
- Prior art keywords
- sustained
- pharmaceutical compositions
- release pharmaceutical
- tablet form
- tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11143080A | 1980-01-11 | 1980-01-11 | |
US06/194,453 US4308251A (en) | 1980-01-11 | 1980-10-17 | Controlled release formulations of orally-active medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ195933A true NZ195933A (en) | 1982-11-23 |
Family
ID=26808896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ195933A NZ195933A (en) | 1980-01-11 | 1980-12-23 | Sustained-release pharmaceutical compositions in tablet form |
Country Status (22)
Country | Link |
---|---|
JP (1) | JPS56103110A (no) |
AT (1) | AT374681B (no) |
AU (1) | AU542824B2 (no) |
BE (1) | BE886998A (no) |
CA (1) | CA1140466A (no) |
CH (1) | CH646604A5 (no) |
DE (1) | DE3100191A1 (no) |
DK (1) | DK6181A (no) |
ES (2) | ES498369A0 (no) |
FI (1) | FI76927C (no) |
FR (1) | FR2473308B1 (no) |
GB (1) | GB2067072B (no) |
GR (1) | GR73843B (no) |
IE (1) | IE50806B1 (no) |
IN (1) | IN151913B (no) |
IT (1) | IT1221041B (no) |
LU (1) | LU83052A1 (no) |
NL (1) | NL8100037A (no) |
NO (1) | NO156153C (no) |
NZ (1) | NZ195933A (no) |
SE (1) | SE447450B (no) |
ZA (1) | ZA81136B (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2496082A (en) * | 1947-05-24 | 1950-01-31 | Ashenfelter William | Scaffold structure |
IT1144911B (it) * | 1981-03-19 | 1986-10-29 | Pharmatec Spa | Composizione farmaceutica a rilascio controllato contenente ibuprofen |
JPS59227817A (ja) * | 1983-06-07 | 1984-12-21 | Toyo Jozo Co Ltd | 持続性経口用ブレデニン製剤 |
JPH0662404B2 (ja) * | 1983-06-14 | 1994-08-17 | シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド | 制御放出性ナプロキセンおよびナプロキセンナトリウム錠 |
ZA836030B (en) * | 1983-08-16 | 1985-02-27 | Verex Lab | Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions |
ZA836031B (en) * | 1983-08-16 | 1985-02-27 | Verex Lab | Constant release rate solid dosage theophylline formulation |
EP0138216B1 (en) * | 1983-10-14 | 1993-01-07 | Sumitomo Pharmaceuticals Company, Limited | Sustained-release ifn preparation for parenteral administration |
US4774091A (en) * | 1983-10-14 | 1988-09-27 | Sumitomo Pharmaceuticals Company, Ltd. | Long-term sustained-release preparation |
US4855134A (en) * | 1983-10-14 | 1989-08-08 | Sumitomo Pharmaceuticals Company, Limited | Sustained-release preparation |
US5385738A (en) * | 1983-10-14 | 1995-01-31 | Sumitomo Pharmaceuticals Company, Ltd. | Sustained-release injection |
EP0230647B1 (en) * | 1985-12-27 | 1993-03-31 | Sumitomo Pharmaceuticals Company, Limited | Method for producing a sustained release formulation |
GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
IL85538A (en) * | 1987-02-27 | 1991-09-16 | Lilly Co Eli | Sustained release matrix tablet formulations containing hydrophilic and enteric polymers |
US4968508A (en) * | 1987-02-27 | 1990-11-06 | Eli Lilly And Company | Sustained release matrix |
AU6403196A (en) * | 1995-06-30 | 1997-02-05 | Baylor University | Polyester/carboxylic acid composite materials |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2953497A (en) * | 1953-06-03 | 1960-09-20 | Howard A Press | Therapeutic tablets |
NL128902C (no) * | 1960-06-06 | |||
US3577514A (en) * | 1968-06-10 | 1971-05-04 | Pfizer | Sustained release pharmaceutical tablets |
US3773920A (en) * | 1971-07-14 | 1973-11-20 | Nikken Chemicals Co Ltd | Sustained release medicinal composition |
US3906086A (en) * | 1971-07-19 | 1975-09-16 | Richard G Powers | Timed-release aspirin |
GB1500300A (en) * | 1975-01-06 | 1978-02-08 | Ciba Geigy Ag | Pharmaceutical preparation for the treatment of circulatory disorders |
JPS5411226A (en) * | 1977-06-24 | 1979-01-27 | Shin Etsu Chem Co Ltd | Disintegratable granule |
-
1980
- 1980-12-23 IN IN1418/CAL/80A patent/IN151913B/en unknown
- 1980-12-23 NZ NZ195933A patent/NZ195933A/xx unknown
-
1981
- 1981-01-05 AU AU65976/81A patent/AU542824B2/en not_active Ceased
- 1981-01-06 FR FR8100087A patent/FR2473308B1/fr not_active Expired
- 1981-01-07 DE DE19813100191 patent/DE3100191A1/de active Granted
- 1981-01-07 NL NL8100037A patent/NL8100037A/nl not_active Application Discontinuation
- 1981-01-08 ES ES498369A patent/ES498369A0/es active Granted
- 1981-01-08 GB GB8100522A patent/GB2067072B/en not_active Expired
- 1981-01-08 BE BE0/203426A patent/BE886998A/fr unknown
- 1981-01-08 CH CH9281A patent/CH646604A5/fr not_active IP Right Cessation
- 1981-01-08 JP JP157881A patent/JPS56103110A/ja active Pending
- 1981-01-08 DK DK6181A patent/DK6181A/da not_active Application Discontinuation
- 1981-01-09 FI FI810056A patent/FI76927C/fi not_active IP Right Cessation
- 1981-01-09 LU LU83052A patent/LU83052A1/fr unknown
- 1981-01-09 IT IT47537/81A patent/IT1221041B/it active
- 1981-01-09 CA CA000368219A patent/CA1140466A/en not_active Expired
- 1981-01-09 ZA ZA00810136A patent/ZA81136B/xx unknown
- 1981-01-09 SE SE8100104A patent/SE447450B/sv not_active IP Right Cessation
- 1981-01-09 NO NO810062A patent/NO156153C/no unknown
- 1981-01-09 IE IE36/81A patent/IE50806B1/en unknown
- 1981-01-09 AT AT0005481A patent/AT374681B/de not_active IP Right Cessation
- 1981-01-09 GR GR63828A patent/GR73843B/el unknown
-
1982
- 1982-01-29 ES ES509179A patent/ES8301629A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
GB2067072A (en) | 1981-07-22 |
FI76927C (fi) | 1989-01-10 |
NO156153B (no) | 1987-04-27 |
SE447450B (sv) | 1986-11-17 |
IN151913B (no) | 1983-09-03 |
ES509179A0 (es) | 1982-12-16 |
FR2473308A1 (fr) | 1981-07-17 |
FI76927B (fi) | 1988-09-30 |
GR73843B (no) | 1984-05-07 |
ZA81136B (en) | 1982-01-27 |
NO810062L (no) | 1981-07-13 |
IE50806B1 (en) | 1986-07-23 |
ES8301629A1 (es) | 1982-12-16 |
JPS56103110A (en) | 1981-08-18 |
IT1221041B (it) | 1990-06-21 |
NL8100037A (nl) | 1981-08-03 |
DE3100191C2 (no) | 1988-09-01 |
AU542824B2 (en) | 1985-03-14 |
GB2067072B (en) | 1983-08-10 |
DK6181A (da) | 1981-07-12 |
AU6597681A (en) | 1981-07-16 |
NO156153C (no) | 1987-08-05 |
ES8205353A1 (es) | 1982-06-01 |
FI810056L (fi) | 1981-07-12 |
AT374681B (de) | 1984-05-25 |
CH646604A5 (fr) | 1984-12-14 |
SE8100104L (sv) | 1981-07-12 |
IT8147537A0 (it) | 1981-01-09 |
IE810036L (en) | 1981-07-11 |
CA1140466A (en) | 1983-02-01 |
DE3100191A1 (de) | 1981-12-10 |
LU83052A1 (fr) | 1982-09-10 |
ATA5481A (de) | 1983-10-15 |
ES498369A0 (es) | 1982-06-01 |
BE886998A (fr) | 1981-07-08 |
FR2473308B1 (fr) | 1985-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA813465B (en) | Pharmaceutical composition | |
DE3172028D1 (en) | Pharmaceutical formulation | |
IL66435A0 (en) | Sustained-release pharmaceutical compositions | |
GB8428369D0 (en) | Pharmaceutical tablets | |
GB8315489D0 (en) | Stable pharmaceutical tablet | |
ZA824622B (en) | Pharmaceutical compositions | |
NZ195933A (en) | Sustained-release pharmaceutical compositions in tablet form | |
PH17562A (en) | 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions | |
ZA825397B (en) | Pharmaceutical compositions | |
ZA816766B (en) | Anti-ischaemic pharmaceutical compositions | |
ZA822856B (en) | Pharmaceutical compositions | |
ZA82652B (en) | Pharmaceutical compositions | |
GB2067900B (en) | Medicinal tablets | |
IL62517A (en) | Pharmaceutical compositions comprising cisplatin | |
DE3176849D1 (en) | Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate | |
PT73952B (en) | Pharmaceutical compositions | |
HK90087A (en) | Pharmaceutical formulation | |
MY8700560A (en) | Pharmaceutical compositions | |
ZA826479B (en) | Pharmaceutical compositions | |
ZA815175B (en) | Pharmaceutical composition | |
AU87660S (en) | Pharmaceutical tablet | |
ZA82186B (en) | Pharmaceutical compositions | |
CA50537S (en) | Pharmaceutical tablet | |
ZA812902B (en) | Pharmaceutical compositions | |
ZA816940B (en) | Pharmaceutical compositions |